Robin Kate Kelley

ORCID: 0000-0002-1984-2430

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center, University of San Francisco

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

14.6Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 37 papers — median percentile 98. Top paper: “An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics”.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Discovering dominant tumor immune archetypes in a pan-cancer census

Cell(2021)10.1016/j.cell.2021.12.004

N/A

4.2DataRank · unranked

176 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +75 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Journal of Clinical Oncology(2024)10.1200/jco-24-01383

N/A

1.1DataRank · unranked

51 citations

Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff +17 more

Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis

Cell Reports(2022)10.1016/j.celrep.2022.111384

N/A

1.1DataRank · unranked

41 citations

Elizabeth McCarthy, Arielle Ilano, Hai Yang, Li Zhang, Kathryn M. Allaire +14 more

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Annals of Oncology(2024)10.1016/j.annonc.2024.02.005

N/A

0.868DataRank · unranked

326 citations

S.L. Chan, R.K. Kelley, G. Lau, M. Kudo, W. Sukeepaisarnjaroen +198 more

Immunology and immunotherapy of cholangiocarcinoma

Nature Reviews Gastroenterology & Hepatology(2023)10.1038/s41575-022-00741-4

N/A

0.787DataRank · unranked

189 citations

Robert F. Schwabe, Nabeel Bardeesy, Lichun Ma, Lipika Goyal, Robin Kate Kelley +2 more

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

The Oncologist(2022)10.1093/oncolo/oyac150

N/A

0.668DataRank · unranked

85 citations

Sunyoung Lee, Nilofer S Azad, Mitesh J Borad, Robin Kate Kelley, Smitha Sivaraman +6 more

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

Hepatology(2024)10.1097/hep.0000000000000800

N/A

0.557DataRank · unranked

40 citations

Donghui Li, Younghun Han, Jinyoung Byun, Rikita Hatia, Erping Long +48 more

A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma

Annals of Oncology(2024)10.1016/j.annonc.2024.12.011

N/A

0.538DataRank · unranked

35 citations

Daniel DiToro, Francesco Facchinetti, E Martin, P. Peng, Islam Baiev +50 more

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101052

N/A

0.520DataRank · unranked

31 citations

Erica C. Pehrsson, Aiwu Ruth He, Lipika Goyal, Robin Kate Kelley, Hien Dang +26 more

HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Cancer Research(2024)10.1158/0008-5472.can-24-0456

N/A

0.218DataRank · unranked

3 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study

JHEP Reports(2025)10.1016/j.jhepr.2025.101685

N/A

0.165DataRank · unranked

2 citations

Tiziana Pressiani, Naoshi Nishida, Shadi Chamseddine, Ashwini Arvind, Michael Li +36 more

Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits

International Journal of Cancer(2025)10.1002/ijc.70136

N/A

0.165DataRank · unranked

2 citations

Vikram R. Shaw, Jinyoung Byun, Aaron P. Thrift, Catherine Zhu, Donghui Li +33 more

Pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Final outcomes of a phase 2 trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.444

N/A

0DataRank · unranked

9 citations

Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, Faaiz Ibrahim, M. Pollak +8 more

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.lba490

N/A

0DataRank · unranked

99 citations

Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin +15 more

Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad046

N/A

0DataRank · unranked

28 citations

Leontios Pappas, Islam Baiev, Jordan R. Maurer, Andrea Grace Bocobo, Karen Zhang +25 more

Evidence and choice: The BCLC vision for tailoring clinical decision-making

Journal of Hepatology(2024)10.1016/j.jhep.2024.04.023

N/A

0DataRank · unranked

3 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more

705 Immunosuppressive CD14 + monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0705

N/A

0DataRank · unranked

0 citations

Bridget P. Keenan, Bryan Le, Quincy Harris, J.J. Chen, Matthew D. Clark +12 more

A Pan-Cancer Census of Dominant Tumor Immune Archetypes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.26.441344

N/A

0DataRank · unranked

4 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +32 more

Supplementary text from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

(2025)10.1158/0008-5472.28431528

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Figure S1 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28431549

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Supplementary Tables 1-8 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28428319

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Figure S3 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28428325

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Figure S3 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28431540

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Supplementary text from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

(2025)10.1158/0008-5472.28428316

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Data from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

(2025)10.1158/0008-5472.c.7676185

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Figure S1 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28428331

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Figure S4 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28428322

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Figure S4 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

(2025)10.1158/0008-5472.28431537

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Journal of Hepatology(2021)10.1016/j.jhep.2021.11.018

N/A

0DataRank · unranked

4206 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more

Figure S2 from HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Figshare(2025)10.1158/0008-5472.28428328

N/A

0DataRank · unranked

0 citations

Adriana Pitea, Gwendolyn M. Jang, Zhong Xu, Huat Chye Lim, Alex L. Choi +22 more

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

Nature Cancer(2022)10.1038/s43018-022-00357-2

N/A

0DataRank · unranked

490 citations

Roser Pinyol, Robin Kate Kelley, Anthony B. El-Khoueiry, Helen L. Reeves, Sophie Wang +3 more

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.150

N/A

0DataRank · unranked

143 citations

Francesco Facchinetti, Daniel DiToro, Islam Baiev, Umair Majeed, Sylvia A. Reyes +24 more

Biliary cancer brain metastases: a multi-institution case series with case reports

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-818

N/A

0DataRank · unranked

5 citations

Karen Zhang, Hriday P. Bhambhvani, Jennifer L. Wild, A. Clark Griffin, Robin Kate Kelley +2 more

Robin Kate Kelley

Indexed papers

Top data-sharing exemplar

Papers